123.47 -0.27(-0.22%) Date:

Johnson & Johnson (JNJ): Street Shrugs Off Pfizer Inc.'s (PFE) Remicade Threat

Analysts weigh in on Johnson and Johnson's prospects as cheaper competition to Remicade looms closer